The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
about
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical careHow Can We Treat Cancer Disease Not Cancer Cells?Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.Pathways and Mechanisms that Prevent Genome Instability in Saccharomyces cerevisiaeAneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.Origins of lymphatic and distant metastases in human colorectal cancer.PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.Genomic Evolution of Breast Cancer Metastasis and Relapse.Genomic landscape of high-grade meningiomas.Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.The evolution of tumour phylogenetics: principles and practice.Epigenetic plasticity and the hallmarks of cancer.Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.Patient-derived xenografts undergo mouse-specific tumor evolution.HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.Hypoxic regulation of the expression of genes encoded estrogen related proteins in U87 glioma cells: eff ect of IRE1 inhibition.Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.Somatic evolutionary timings of driver mutations.Untangling the genetics from the epigenetics in pancreatic cancer metastasis.Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.Loss of Chromatin Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological MalignanciesTargeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too LateTiming somatic events in the evolution of cancerMechanisms of acquired resistance to rapalogs in metastatic renal cell carcinomaA distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutationsGenomics of adult and pediatric solid tumors
P2860
Q28078792-F05F9482-1EF2-4D80-B9C5-9E2E3B7D8E6CQ28558823-F4F02AF9-2A5B-4162-8FA7-561ACC307989Q33648936-41BCD328-93F0-40F0-905D-33F5276C5938Q33879989-3FFF481D-6AB4-4B75-8D5D-EB7E1ED9CD54Q37706048-8697FD84-433D-4117-90FA-1EB676F2A0FFQ38373329-0BE0E41E-4DC8-4B89-BBC8-BF812860A872Q38599066-E44F7F86-FCE2-4F74-8DFD-596E7E6ACE5EQ38623761-F0B9F28A-55C2-43D3-B1C8-ABCFF1F3BBA1Q38676440-86288CB7-8F8E-40D2-8A81-146F0E4BB446Q38769887-392984A6-47DC-4D1E-AD02-37F89C4A5458Q39132571-881CDFA9-81A4-4A21-B741-F259A4B042D4Q39448979-DEEE121D-18A9-4355-8DC1-4BD337E37315Q41198823-283BA913-38EB-4AB7-B13E-9A7D7209121FQ41436943-02D01679-EF84-444E-983B-186874A13F5EQ45395608-2D06194E-049B-4D76-A7B3-77A6BF8FEF23Q46291099-FB403D28-DC1F-41CA-95E3-EB2E4E0EDB14Q47370686-23C7E8DB-D9C5-4E2A-9E3D-2D057CA6CE06Q47404707-C3040B00-66E1-459F-8AC7-649482297D20Q47956425-E75E4B7A-5DDD-4FF7-B81B-6D83A72EA29CQ47968758-F6D46410-F382-4708-992C-60093FFCD839Q48170773-C63F9945-8810-4A09-8325-F8CD407BF679Q49396578-1A364CD7-2651-4FF1-A951-7326526E7864Q51124914-93D4000D-8AC6-452E-9A7E-3E1F3941E7C5Q51418643-AADCCB81-E767-4854-9081-60BFAD09C8FCQ52586328-3B4BA8F0-43CA-4110-87B1-58E9B98F2066Q52688905-CD5998A8-1AA5-4546-B66D-D451027CCAC9Q56365972-0C2E1313-CE8E-40A5-BC85-6437253C4412Q57169683-8F461C76-3B2C-4257-A724-1353A8CF8EF7Q58063735-27372BEB-8820-4C3A-82D4-627977B29AF7Q58693750-DC9824B5-BE93-4272-9FD3-569FBF211988Q58718413-C7BFF886-F356-4274-BC7F-AC29A2944AC4Q58804574-8D505D94-6342-4601-9346-3E3FAF86A7C5
P2860
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The genomic landscape and evol ...... and abdominopelvic metastasis.
@en
The genomic landscape and evol ...... and abdominopelvic metastasis.
@nl
type
label
The genomic landscape and evol ...... and abdominopelvic metastasis.
@en
The genomic landscape and evol ...... and abdominopelvic metastasis.
@nl
altLabel
The genomic landscape and evol ...... and abdominopelvic metastasis
@en
prefLabel
The genomic landscape and evol ...... and abdominopelvic metastasis.
@en
The genomic landscape and evol ...... and abdominopelvic metastasis.
@nl
P2093
P2860
P50
P356
P1433
P1476
The genomic landscape and evol ...... and abdominopelvic metastasis.
@en
P2093
Aaron Chevalier
Andrew D Cherniack
Eran Hodis
Erling A Hoivik
Helga B Salvesen
Henrica M J Werner
Ingunn M Stefansson
Jeremiah A Wala
Kanthida Kusonmano
P2860
P2888
P304
P356
10.1038/NG.3602
P407
P577
2016-06-27T00:00:00Z
P6179
1008619203